KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.1880
-0.0720 (-27.69%)
At close: Oct 14, 2026, 4:00 PM EDT
0.1940
+0.0060 (3.19%)
After-hours: Oct 14, 2026, 7:49 PM EDT
KALA BIO Employees
KALA BIO had 6 employees as of December 31, 2025. The number of employees decreased by 32 or -84.21% compared to the previous year. That makes KALA BIO the 41,347th largest employer in the world and 6,398th in the United States.
Employees
6
Change (1Y)
-32
Growth (1Y)
-84.21%
Revenue / Employee
n/a
Profits / Employee
-$1,680,000
Market Cap
3.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -32 | -84.21% |
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Enlivex | 34 |
| Lunai Bioworks | 29 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Azitra | 13 |
| NuCana | 12 |
| Lexaria Bioscience | 7 |
| Creative Medical Technology Holdings | 4 |
KALA News
- 15 days ago - KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception - Newsfile Corp
- 20 days ago - KALA BIO Proxy statement: Proxy filing - Filings
- 20 days ago - Kala Bio, Virotek sign letter of intent with U.S. DNA testing platform - TheFly
- 20 days ago - Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products - GlobeNewsWire
- 27 days ago - KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team - GlobeNewsWire
- 4 weeks ago - KALA BIO Proxy statement: Proxy filing - Filings
- 5 weeks ago - Kala Bio, Virotek announce exclusive distribution and reseller agreement - TheFly
- 5 weeks ago - Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program - GlobeNewsWire